Difference between revisions of "Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[checked revision][checked revision]
(Rejected the last text change (by TestEditor) and restored revision 14169 by Bailey.Glen)
 
(132 intermediate revisions by 12 users not shown)
Line 1: Line 1:
Welcome!
+
Welcome!  
  
*For assignments, please see the "Author" column below.  If no name is present, volunteer to create content!
 
*We will be creating content for all entities with genetic findings in the current WHO Classification of Tumours books.  If there is an entity not yet listed below that you would like to author, we would be happy to create a page for you now.
 
*To volunteer, please '''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' with your page of interest.
 
__TOC__
 
  
==WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content==
+
We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books.  Please join the effort!  
{| class="wikitable"
+
 
|-
+
 
!'''Disease'''!!'''Page Type'''!!'''Author'''
+
To volunteer:  
!'''Date Assigned to Author'''
+
 
!'''Target Completion Date'''
+
#Select a link in the table to your book(s) of interest to view specific authorship opportunitiesAdditional books are in the process of being added.
!'''Author Content (Pending or Complete)'''
+
#'''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' with your disease page of interestYou will be connected with an Associate Editor to help guide you through the process.
!'''Date Completed by Author'''!!'''Associate Editor'''
+
#Complete the brief '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]''' to receive your log-in credentialsInformation on [[Description of CCGA Roles|<u>Authorship and Other Roles</u>]] with the CCGA is available.
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
|-
 
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
 
|
 
|
 
|complete
 
|
 
|Fabiola Quintero-Rivera (FQR)
 
|Date page was created
 
|
 
|-
 
|    Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive||Disease
 
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
 
|
 
|
 
|complete
 
|
 
|FQR
 
|Date page was created
 
|
 
|-
 
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
 
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
 
|
 
|
 
|complete
 
|
 
|FQR
 
|Date page was created
 
|
 
|-
 
|    Polycythaemia Vera  (PV)||Disease
 
|Gokce A. Toruner
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Primary Myelofibrosis (PMF)||Disease
 
|T. Niroshi  Senaratne
 
|
 
|
 
|complete
 
|
 
|FQR
 
|8/4/2020 before submission
 
|
 
|-
 
|    Essential  Thrombocythaemia (ET)||Disease
 
|Rebecca Smith
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|8/1/21 FQR deleted "'''This page is under construction'''
 
|-
 
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
 
|Chelsea D. Kramish (trainee), Daynna J.Wolff
 
|
 
|
 
|complete/pending faculty review
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
 
|Thomas Lee
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|'''''Mastocytosis'''''||'''''Overview'''''||Shashi Shetty, Ph.D.
 
|
 
|
 
|complete
 
| ||FQR
 
|
 
|
 
|-
 
|    Cutaneous  Mastocytosis||Disease
 
|Thuy Phung + Shuo-Shawn Liu (trainee)
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|8/1/21 FQR deleted "'''This page is under construction'''
 
|-
 
|    Systemic Mastocytosis||Disease
 
|Shashi Shetty
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Mast Cell Sarcoma||Disease
 
|Thuy Phung +Jordan Lowery (trainee)
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
 
|Disease
 
|Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|NON-WHO ENTITY
 
|-
 
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
 
|Disease
 
|Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|NON-WHO ENTITY
 
|-
 
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
 
|
 
|9/1/20
 
|PENDING importing content and reference formatting
 
|
 
|FQR
 
|
 
|FQR has emailed SR several times, last 4/20/22
 
|-
 
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
 
|
 
|
 
|complete
 
|
 
|FQR
 
|Date page was created
 
|
 
|-
 
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Jack Reid (trainee)+Fabiola Quintero-Rivera
 
|
 
|4/21/22
 
|pending
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
 
|
 
|9/1/20
 
|PENDING
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 
|
 
|9/1/20
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|
 
|
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|
 
|
 
|complete
 
|
 
|FQR
 
|
 
|
 
|-
 
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 
|
 
|9/1/20
 
|Complete
 
|
 
|FQR
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
 
|
 
|
 
|Complete
 
|
 
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
 
|04/26/2021 -MS (re-review)
 
|
 
|-
 
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|03/01/2021-MS (re-review)
 
|
 
|-
 
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
 
|
 
|
 
|PENDING
 
| ||JH / MS
 
|04/26/2021 -MS (re-review)
 
|
 
|-
 
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|03/01/2021-MS
 
|
 
|-
 
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
 
|
 
|
 
|Complete
 
|02/03/2021||JH / MS
 
|
 
|
 
|-
 
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|03/02/2021-MS
 
|
 
|-
 
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|03/02/2021-MS (re-review)
 
|
 
|-
 
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|04/26/2021 -MS (re-review)
 
|
 
|-
 
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
 
|
 
|
 
|Complete
 
|
 
|JH / MS
 
|03/01/2021-MS (re-review)
 
|
 
|-
 
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|04/26/2021-MS (re-review)
 
|
 
|-
 
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|03/01/2021-MS (re-review)
 
|
 
|-
 
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|03/01/2021-MS (re-review)
 
|
 
|-
 
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|03/01/2021-MS (re-review)
 
|
 
|-
 
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|02/24/2021-MS (re-review)
 
|
 
|-
 
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|Need permission for figure? Update WHO?
 
|-
 
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg
 
Corboy (Monash Health)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|Add WHO reference
 
|-
 
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Corboy (Monash Health)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|Check reference format
 
|-
 
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|Need permission for figure?
 
|-
 
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|Check reference format
 
|-
 
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
 
|
 
|
 
|Complete
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Mixed-Phenotype Acute Leukemia, Not  Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
 
|
 
|
 
|PENDING
 
| ||JH / MS
 
|
 
|
 
|-
 
|    Acute Leukemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
 
|
 
|
 
|PENDING
 
| ||JH / MS
 
|
 
|
 
|-
 
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
 
|Disease
 
|Kay Weng Choy + Greg Corboy (Monash Health)
 
|
 
|
 
|Complete
 
|
 
|JH / MS
 
|
 
|NON-WHO ENTITY
 
|-
 
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
 
|Disease
 
|Daynna Wolff+Jessica Snider (Path Resident)
 
|
 
|
 
|PENDING
 
|
 
|JH / MS
 
|
 
|NON-WHO ENTITY
 
|-
 
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
 
|Disease
 
|Daynna Wolff+ Paige Woodham (Path Resident)
 
|
 
|
 
|PENDING
 
|
 
|JH / MS
 
|
 
|NON-WHO ENTITY
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||Yassmine Akkari (YA)
 
|
 
|
 
|-
 
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||YA
 
|
 
|
 
|-
 
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain (trainee) + Yassmine Akkari
 
|
 
|
 
|PENDING
 
| ||YA
 
|
 
|
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
 
|
 
|
 
|PENDING
 
|
 
|YA
 
|
 
|
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
 
|
 
|
 
|PENDING
 
| ||YA
 
|
 
|
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
 
|
 
|
 
|PENDING
 
| ||YA
 
|
 
|
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +
 
  
Lisa Smith + Yassmine Akkari
 
|
 
|
 
|Complete
 
|
 
|YA
 
|
 
|
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
 
|
 
|
 
|PENDING
 
| ||YA
 
|
 
|
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
 
|
 
|
 
|PENDING
 
| ||YA
 
|
 
|
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
 
|
 
|
 
|Complete
 
|
 
|YA
 
|
 
|
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
 
|
 
|
 
|Complete
 
| ||YA
 
|
 
|
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
 
|
 
|
 
|PENDING
 
| ||YA
 
|
 
|
 
|-
 
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
 
|Disease
 
|Diana Rush
 
|
 
|
 
|PENDING
 
|
 
|YA
 
|
 
|NON-WHO ENTITY
 
|-
 
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
 
|Disease
 
|Celeste Eno
 
|
 
|
 
|PENDING
 
|
 
|YA
 
|
 
|NON-WHO ENTITY
 
|-
 
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
 
|Disease
 
|Marilena Melas
 
|
 
|
 
|PENDING
 
|
 
|YA
 
|
 
|NON-WHO ENTITY
 
|-
 
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
 
|Disease
 
|Chenkai Ma
 
|
 
|
 
|PENDING
 
|
 
|YA
 
|
 
|NON-WHO ENTITY
 
|-
 
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
 
|Disease
 
|Celeste Eno
 
|
 
|
 
|PENDING
 
|
 
|YA
 
|
 
|NON-WHO ENTITY
 
|-
 
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
 
|Disease
 
|Alaa Koleilat
 
|
 
|
 
|PENDING
 
|
 
|YA
 
|
 
|NON-WHO ENTITY
 
|-
 
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
 
|
 
|
 
|PENDING
 
| ||YA
 
|
 
|
 
|-
 
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
 
|
 
|
 
|PENDING
 
| ||YA
 
|
 
|2021 template added
 
|-
 
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
 
|
 
|
 
|PENDING
 
| ||YA
 
|
 
|2021 template added
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||Snehal Patel (SP)
 
|
 
|
 
|-
 
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Jamie Nagy
 
|10/25/21
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|       Monoclonal B-cell  Lymphocytosis||Disease||
 
|
 
|
 
|
 
|
 
|SP
 
|
 
|
 
|-
 
|B-cell Prolymphocytic Leukemia||Disease||Zejuan Li
 
|4/28/22
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|2021 template added
 
|-
 
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
 
|
 
|
 
|Complete
 
|
 
|SP
 
|
 
|
 
|-
 
|Hairy Cell Leukemia||Disease||Snehal Patel
 
|
 
|
 
|Complete
 
|
 
|SP
 
|
 
|
 
|-
 
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
 
|
 
|
 
|Complete
 
|
 
|SP
 
|
 
|
 
|-
 
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
 
|
 
|
 
|Complete
 
|
 
|SP
 
|
 
|
 
|-
 
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
 
|
 
|
 
|Complete
 
|
 
|SP
 
|
 
|
 
|-
 
|Lymphoplasmacytic Lymphoma||Disease||Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|2021 template added
 
|-
 
|   Waldenstrom  Macroglobulinemia||Disease||Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|2021 template added
 
|-
 
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
 
|
 
|
 
|
 
| ||SP
 
|
 
|
 
|-
 
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||SP
 
|
 
|
 
|-
 
|    Mu Heavy Chain  Disease||Disease||Manisha Sutariya
 
|
 
|
 
|
 
| ||SP
 
|
 
|
 
|-
 
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
 
|
 
|
 
|Complete
 
|5/26/2021||SP
 
|
 
|
 
|-
 
|    Alpha Heavy Chain  Disease||Disease||
 
|
 
|
 
|
 
| ||SP
 
|
 
|
 
|-
 
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|    Plasmacytoma||Disease||Zhenya Tang
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||Chen Yang, MD, PhD
 
|
 
|
 
|?PENDING
 
| ||SP
 
|
 
|
 
|-
 
|           Primary  Amyloidosis||Disease||Heather E. Williams, PhD
 
|
 
|
 
|?PENDING
 
| ||SP
 
|
 
|
 
|-
 
|           Light Chain  and Heavy Chain Deposition Disease||Disease||Chen Yang, MD, PhD
 
|
 
|
 
|?PENDING
 
| ||SP
 
|
 
|
 
|-
 
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||Sohini Anand
 
|8/31/2021
 
|9/15/2021
 
|PENDING
 
| ||SP
 
|
 
|
 
|-
 
|         POEMS Syndrome||Disease||Sohini Anand, MBBS, and Tharanga Niroshini Senaratne, PhD
 
|
 
|
 
|?PENDING
 
| ||SP
 
|
 
|
 
|-
 
|         TEMPI Syndrome||Disease||Sohini Anand, MBBS
 
|
 
|
 
|?PENDING
 
| ||SP
 
|
 
|
 
|-
 
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee (trainee)/Fabiola Quintero-Rivera
 
|3/9/21
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|2021 template added
 
|-
 
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
 
|
 
|
 
|Complete
 
|5/28/2021||SP
 
|
 
|
 
|-
 
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
 
|
 
|
 
|Complete
 
|11/11/2020
 
|SP
 
|
 
|
 
|-
 
|Follicular Lymphoma||Disease||Ruthann Pfau
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
 
|
 
|
 
|Complete
 
|8/16/2020
 
|SP
 
|
 
|
 
|-
 
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
 
|
 
|9/30/20
 
|Complete
 
|5/26/2021||SP
 
|
 
|
 
|-
 
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
 
|
 
|
 
|PENDING
 
| ||SP
 
|
 
|
 
|-
 
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
|
 
|8/15/20
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari, MD
 
|
 
|
 
|?PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|    In Situ Mantle Cell  Neoplasia||Disease||
 
|
 
|
 
|
 
|
 
|SP
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
 
|
 
|
 
|PENDING
 
|
 
|Greg Corboy (GC)
 
|
 
|Requested to update 14022022
 
|-
 
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||Laveniya Satgunaseelan
 
|26/10/2021
 
|26/1/2022
 
|Complete
 
|03/28/22||GC
 
|03/28/22
 
|2021 template added
 
|-
 
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|EBV-Positive Mucocutaneous Ulcer||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Lymphomatoid Granulomatosis||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Intravascular Large B-cell Lymphoma||Disease||Kate Berry, Greg Corboy
 
|25/01/2022
 
|25/4/2022
 
|PENDING
 
| ||GC
 
|
 
|Emailed 28/3/2022 for progress update
 
|-
 
|ALK-Positive Large B-cell Lymphoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|Nakasaki Manando removed March 2022 due to no progress/contact 1y
 
|-
 
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
 
|
 
|
 
|Complete
 
| ||GC
 
|28/03/2022
 
|
 
|-
 
|Primary Effusion Lymphoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|   Multicentric Castleman  Disease||Disease||Sudha Arumugam
 
|10/26/2021
 
|1/26/2022
 
|Complete
 
|24/01/2022||GC
 
|24/01/2022
 
|2021 template added
 
|-
 
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Xiao Zhou, MD, PhD, Siparadigm
 
|10/26/2021
 
|1/26/2022
 
|PENDING
 
| ||GC
 
|
 
|Emailed 28/3/2022 for progress update
 
|-
 
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||Xiao Zhou, MD, PhD, Siparadigm
 
|10/26/2021
 
|1/26/2022
 
|PENDING
 
| ||GC
 
|
 
|Emailed 28/3/2022 for progress update
 
|-
 
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
 
|3/11/21
 
|06/28/2021
 
|Complete
 
|28/06/2021||GC
 
|28/06/2021
 
|
 
|-
 
|Burkitt-Like Lymphoma with 11q Aberration||Disease||Lauren Shealy (trainee), Daynna Wolff
 
|10/13/21
 
|01/13/2022
 
|Complete
 
|27/01/2022
 
|GC
 
|27/01/2021
 
|2021 template added
 
|-
 
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||Kate Berry, Greg Corboy
 
|30/05/21
 
|30/08/21
 
|Complete
 
|24/02/2022||GC
 
|24/02/2022
 
|
 
|-
 
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Aiko Otsubo, Holli Drendel
 
|7/30/21
 
|10/30/21
 
|Complete
 
|15/11/2021
 
|GC
 
|16/11/2021
 
|
 
|-
 
|B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||Snehal Patel (SP)
 
|
 
|
 
|-
 
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
 
|
 
|
 
|PENDING
 
| ||SP
 
|
 
|
 
|-
 
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
 
|
 
|
 
|PENDING
 
| ||SP
 
|
 
|
 
|-
 
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
 
|
 
|
 
|PENDING
 
| ||SP
 
|
 
|
 
|-
 
|Aggressive NK-cell Leukemia||Disease||Shanelle De Lancy, MD, Shashirekha Shetty, PhD
 
|
 
|
 
|?PENDING
 
| ||SP
 
|
 
|
 
|-
 
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||SP
 
|
 
|
 
|-
 
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
 
|
 
|
 
|Complete
 
|11/21/2021||SP
 
|
 
|
 
|-
 
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
 
|
 
|
 
|
 
| ||SP
 
|
 
|
 
|-
 
|    Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease||
 
|
 
|
 
|
 
| ||SP
 
|
 
|
 
|-
 
|    Severe Mosquito Bite  Allergy||Disease||
 
|
 
|
 
|
 
| ||SP
 
|
 
|
 
|-
 
|Adult T-cell Leukemia/Lymphoma||Disease||Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG
 
|
 
|
 
|?PENDING
 
| ||SP
 
|
 
|
 
|-
 
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
 
|
 
|
 
|
 
| ||SP
 
|
 
|
 
|-
 
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
|
 
|
 
|Complete
 
|1/21/2021
 
|SP
 
|
 
|
 
|-
 
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
 
|
 
|
 
|Complete
 
|1/21/2021
 
|SP
 
|
 
|
 
|-
 
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
 
|
 
|
 
|
 
| ||SP
 
|
 
|
 
|-
 
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
 
|
 
|
 
|PENDING
 
| ||SP
 
|
 
|
 
|-
 
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
 
|
 
|
 
|PENDING
 
| ||SP
 
|
 
|
 
|-
 
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||Peining Li, PhD
 
|
 
|
 
|PENDING
 
| ||SP
 
|
 
|
 
|-
 
|    Lymphomatoid  Papulosis||Disease||Peining Li, PhD
 
|
 
|
 
|PENDING
 
| ||SP
 
|
 
|
 
|-
 
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||Theresa Spivey, MD, Shashirekha Shetty, PhD
 
|
 
|
 
|PENDING
 
| ||SP
 
|
 
|
 
|-
 
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||Peining Li, PhD
 
|
 
|
 
|PENDING
 
| ||SP
 
|
 
|
 
|-
 
|     Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease||Peining Li, PhD
 
|
 
|
 
|PENDING
 
| ||SP
 
|
 
|
 
|-
 
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||Peining Li, PhD
 
|
 
|
 
|PENDING
 
| ||SP
 
|
 
|
 
|-
 
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||Peining Li, PhD
 
|
 
|
 
|PENDING
 
| ||SP
 
|
 
|
 
|-
 
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||Peining Li, PhD
 
|
 
|
 
|PENDING
 
| ||SP
 
|
 
|
 
|-
 
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
 
|
 
|
 
|
 
| ||SP
 
|
 
|
 
|-
 
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||SP
 
|
 
|
 
|-
 
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
 
|
 
|
 
|PENDING
 
| ||SP
 
|
 
|
 
|-
 
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
 
|
 
|
 
|PENDING
 
|
 
|SP
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||Greg Corboy (GC)
 
|
 
|
 
|-
 
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||Xiaolin (Lynn) Hu
 
|
 
|
 
|Completed
 
|03/21/22||GC
 
|03/21/22
 
|Edits sent 14022022
 
|-
 
|    Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
 
|
 
|
 
|PENDING
 
| ||GC
 
|
 
|2021 template added
 
|-
 
|    Mixed Cellularity Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
 
|
 
|
 
|PENDING
 
| ||GC
 
|
 
|2021 template added
 
|-
 
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
 
|
 
|
 
|PENDING
 
| ||GC
 
|
 
|2021 template added
 
|-
 
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Lymphomas Associated with HIV Infection||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
 
|11/2/21
 
|02/02/22
 
|Completed
 
|03/21/22
 
|GC
 
|03/21/22
 
|2021 template added
 
|-
 
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Ania Shestakova (trainee) + Fabiola Quintero-Rivera
 
|
 
|
 
|completed
 
|april 2022
 
|GC
 
|26/4/2022
 
|
 
|-
 
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|          Monomorphic  B-cell PTLD||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|          Monomorphic  T/NK-cell PTLD||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Histiocytic Sarcoma||Disease||Marie-France Gagnon, MD, Mayo Clinic (LGG fellow trainee), Xinjie Xu, PhD FACMG, Mayo Clinic
 
|
 
|
 
|Complete
 
|10/01/2021
 
|GC
 
|10/01/2021
 
|Xinjie Xu
 
|-
 
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|   Langerhans Cell  Histiocytosis||Disease||Malaika Perchard, Greg Corboy
 
|02/01/2022
 
|05/01/2022
 
|Complete
 
|04/28/2022||GC
 
|5/19/2022
 
|
 
|-
 
|   Langerhans Cell  Sarcoma||Disease||Malaika Perchard, Greg Corboy
 
|02/01/2022
 
|05/01/2022
 
|Complete
 
|04/28/2022||GC
 
|5/19/2022
 
|
 
|-
 
|Indeterminate Dendritic Cell Tumour||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Interdigitating Dendritic Cell Sarcoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Follicular Dendritic Cell Sarcoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Fibroblastic Reticular Cell Tumor||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Disseminated Juvenile Xanthogranuloma||Disease||
 
|
 
|
 
|
 
| ||GC
 
|
 
|
 
|-
 
|Erdheim-Chester Disease||Disease||Prashant Deshpande
 
|02/02/2022
 
|05/02/2022
 
|PENDING
 
| ||GC
 
|
 
|emailed 28/3/2022 to get update
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|-
 
| || ||
 
|
 
|
 
|
 
| ||
 
|
 
|
 
|}<br />
 
  
==WHO Classification of Tumours of the Central Nervous System Content==
 
 
{| class="wikitable"
 
{| class="wikitable"
 +
|+BOOKS WITH CONTENT IN PROGRESS
 +
!Book Name
 +
!Book Edition
 +
!Book Acronym
 
|-
 
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
+
|[[HAEM5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues]]
!'''Date Assigned to Author'''
+
|5th
!'''Target Completion Date'''
+
|HAEM5
!'''Author Content (Pending or Complete)'''
 
!'''Date Completed by Author'''!!'''Associate Editor'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
 
|-
 
|-
|Medulloblastoma, WNT-activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
+
|[[CNS5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Central Nervous System]]
|9/20/21
+
|5th
|
+
|CNS5
|PENDING
 
|
 
|Holli Drendel (interim)
 
|
 
|2021 template added
 
 
|-
 
|-
|Paediatric-Type Diffuse High-Grade Gliomas
+
|[[GTS5:Volunteer Assignments and Opportunities|WHO Classification of Genetic Tumour Syndromes]]
|Overview
+
|5th
|
+
|GTS5
|
 
|
 
|
 
|
 
|
 
|
 
|2021 template added
 
 
|-
 
|-
|Diffuse Midline Glioma, H3 K27-Altered
+
|[[BRST5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Breast]]
|Disease
+
|5th
|Laveniya Satgunaseelan (Linda Cooley - previous version)
+
|BRST5
|
 
|
 
|
 
|
 
|Laveniya Satgunaseelan (LS)
 
|
 
|2021 template added
 
 
|-
 
|-
|Diffuse Hemispheric Glioma, H3 G34-Mutant
+
|[[STBT5:Volunteer Assignments and Opportunities|WHO Classification of Soft Tissue and Bone Tumours]]
|Disease
+
|5th
|Xiaolin (Lynn) Hu
+
|STBT5
|2/21/2022
 
|
 
|PENDING
 
|
 
|LS
 
|
 
|2021 template added
 
 
|-
 
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype
+
|[[DIG5:Volunteer Assignments and Opportunities|WHO Classification of Digestive System Tumours]]
|Disease
+
|5th
|
+
|DIG5
|
+
|}
|
+
 
|
 
|
 
|
 
|
 
|2021 template added
 
|-
 
|Infant-Type Hemispheric Glioma
 
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|2021 template added
 
|-
 
|Astrocytoma, IDH-Mutant
 
|Disease
 
|Riley Lochner (trainee), Shashi Shetty (mentor)
 
|3/3/2022
 
|
 
|PENDING
 
|
 
|LS
 
|
 
|2021 template added
 
|-
 
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
 
|Disease
 
|Riley Lochner (trainee), Shashi Shetty (mentor)
 
|3/3/2022
 
|
 
|PENDING
 
|
 
|LS
 
|
 
|2021 template added
 
|-
 
|}<br />
 
  
==WHO Classification of Soft Tissue and Bone Tumours Content==
 
 
{| class="wikitable"
 
{| class="wikitable"
 +
|+BOOKS COMING SOON
 +
!Book Name
 +
!Book Edition
 +
!Book Acronym
 
|-
 
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
+
|[[EYE5:Volunteer Assignments and Opportunities|WHO Classification of Eye and Orbit Tumours]]
!'''Date Assigned to Author'''
+
|5th
!'''Target Completion Date'''
+
|EYE5
!'''Author Content (Pending or Complete)'''
 
!'''Date Completed by Author'''!!'''Associate Editor'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
|-
 
|NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD
 
|2/20/2022
 
|
 
|PENDING
 
|
 
|Alanna Church
 
|
 
|
 
|-
 
|}<br />
 
 
 
==Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)==
 
{| class="wikitable sortable"
 
!'''Gene'''
 
!'''Author'''
 
!'''Date Assigned to Author'''
 
!'''Target Completion Date'''
 
!'''Author Content (Pending or Complete)'''
 
!'''Date Completed by Author'''
 
!'''Associate Editor'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
|-
 
|BCR
 
|Brian Davis
 
|
 
|
 
|Complete
 
|8/10/18
 
|
 
|
 
|
 
|-
 
|ABL1
 
|Brian Davis
 
|
 
|
 
|Complete
 
|4/16/19
 
|
 
|
 
|
 
|-
 
|RUNX1
 
|Brian Davis
 
|
 
|
 
|Complete
 
|6/9/19
 
|
 
|
 
|
 
|-
 
|RUNX1T1
 
|Brian Davis
 
|
 
|
 
|Complete
 
|5/23/19
 
|
 
|
 
|
 
|-
 
|MYH11
 
|Brian Davis
 
|
 
|
 
|Complete
 
|8/6/18
 
|
 
|
 
|
 
|-
 
|FLT3
 
|Kay Weng Choy
 
|
 
|
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|NPM1
 
|Kay Weng Choy
 
|
 
|
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|TP53
 
|Kay Weng Choy
 
|
 
|
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|DNMT3A
 
|Kay Weng Choy
 
|
 
|
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|CEBPA
 
|Gordana
 
|
 
|
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|IDH1
 
|Paul De Fazio
 
|
 
|
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|IDH2
 
|Paul De Fazio
 
|
 
|
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|PML
 
|Brian Davis
 
|
 
|
 
|Complete
 
|12/5/18
 
|
 
|
 
|
 
|-
 
|RARA
 
|Brian Davis
 
|
 
|
 
|Complete
 
|8/3/18
 
|
 
|
 
|
 
|-
 
|ETV6
 
|Brian Davis
 
|
 
|
 
|Complete
 
|6/9/19
 
|
 
|
 
|
 
|-
 
|KIT
 
|Brian Davis
 
|
 
|
 
|Complete
 
|10/1/18
 
|
 
|
 
|
 
|-
 
|CBFB
 
|Brian Davis
 
|
 
|
 
|Complete
 
|8/2/18
 
|
 
|
 
|
 
|-
 
|GATA2
 
|Kay Weng Choy
 
|
 
|
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|PTEN
 
|Beth Pitel
 
|
 
|
 
|Pending
 
|
 
|
 
|
 
|
 
|-
 
|MLTT3
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|MECOM
 
|Brian Davis
 
|
 
|
 
|Pending
 
|
 
|
 
|
 
|
 
|-
 
|FGFR1(FLT2)
 
|Brian Davis
 
|
 
|
 
|Pending
 
|
 
|
 
|
 
|
 
|-
 
|KMT2A
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|DEK
 
|Wahab A. Khan
 
|
 
|
 
|Pending
 
|
 
|
 
|
 
|
 
|-
 
|NUP214
 
|Wahab A. Khan
 
|
 
|
 
|Pending
 
|
 
|
 
|
 
|
 
|-
 
|RBM15
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|MKL1
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|DDX41
 
|Ying Zou
 
|8/7/20
 
|
 
|Pending
 
|
 
|
 
|
 
|
 
|-
 
|ANKRD26
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|CUX1
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|TET2
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|EZH2
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|FOXP1
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|MYC
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|JAK2
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|WT1
 
|DONE
 
|
 
|
 
|DONE
 
|
 
|
 
|
 
|
 
|-
 
|CBL
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|NF1
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|SUZ12
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|ERG
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|EST2
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|RPS14
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|RB1
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|MPL
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|CHGA
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|CDH1
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|SRSF2
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|DNMT1
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|PRDX2
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|ASXL1
 
|DONE
 
|
 
|
 
|DONE
 
|
 
|
 
|
 
|
 
|-
 
|MN1
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
 
|-
 
|-
|SF3A1
+
|[[SKIN5:Volunteer Assignments and Opportunities|WHO Classification of Skin Tumours]]
|
+
|5th
|
+
|SKIN5
|
 
|
 
|
 
|
 
|
 
|
 
 
|-
 
|-
|EP300
+
|[[HAN5:Volunteer Assignments and Opportunities|WHO Classification of Head and Neck Tumours]]
|
+
|5th
|
+
|HAN5
|
 
|
 
|
 
|
 
|
 
|
 
 
|-
 
|-
|JARID2
+
|[[ENDO5:Volunteer Assignments and Opportunities|WHO Classification of Endocrine and Neuroendocrine Tumours]]
|
+
|5th
|
+
|ENDO5
|
 
|
 
|
 
|
 
|
 
|
 
 
|-
 
|-
|BRCA1
+
|[[MALE5:Volunteer Assignments and Opportunities|WHO Classification of Urinary and Male Genital Tumours]]
|
+
|5th
|
+
|MALE5
|
 
|
 
|
 
|
 
|
 
|
 
 
|-
 
|-
|BRCA2
+
|[[PEDS5:Volunteer Assignments and Opportunities|WHO Classification of Paediatric Tumours]]
|
+
|5th
|
+
|PEDS5
|
 
|
 
|
 
|
 
|
 
|
 
 
|-
 
|-
|
+
|[[THOR5:Volunteer Assignments and Opportunities|WHO Classification of Thoracic Tumours]]
|
+
|5th
|
+
|THOR5
|
 
|
 
|
 
|
 
|
 
|
 
 
|-
 
|-
|
+
|[[FEMA5:Volunteer Assignments and Opportunities|WHO Classification of Female Genital Tumours]]
|
+
|5th
|
+
|FEMA5
|
 
|
 
|
 
|
 
|
 
|
 
 
|}
 
|}

Latest revision as of 13:26, 22 February 2024

Welcome!


We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books. Please join the effort!


To volunteer:

  1. Select a link in the table to your book(s) of interest to view specific authorship opportunities. Additional books are in the process of being added.
  2. Contact us with your disease page of interest. You will be connected with an Associate Editor to help guide you through the process.
  3. Complete the brief Volunteer Form to receive your log-in credentials. Information on Authorship and Other Roles with the CCGA is available.


BOOKS WITH CONTENT IN PROGRESS
Book Name Book Edition Book Acronym
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 5th HAEM5
WHO Classification of Tumours of the Central Nervous System 5th CNS5
WHO Classification of Genetic Tumour Syndromes 5th GTS5
WHO Classification of Tumours of the Breast 5th BRST5
WHO Classification of Soft Tissue and Bone Tumours 5th STBT5
WHO Classification of Digestive System Tumours 5th DIG5


BOOKS COMING SOON
Book Name Book Edition Book Acronym
WHO Classification of Eye and Orbit Tumours 5th EYE5
WHO Classification of Skin Tumours 5th SKIN5
WHO Classification of Head and Neck Tumours 5th HAN5
WHO Classification of Endocrine and Neuroendocrine Tumours 5th ENDO5
WHO Classification of Urinary and Male Genital Tumours 5th MALE5
WHO Classification of Paediatric Tumours 5th PEDS5
WHO Classification of Thoracic Tumours 5th THOR5
WHO Classification of Female Genital Tumours 5th FEMA5